Workneh Gelane, Scherzer Leah, Kirk Brianna, Draper Heather R, Anabwani Gabriel, Wanless R Sebastian, Jibril Haruna, Gaetsewe Neo, Thuto Boitumelo, Tolle Michael A
Botswana-Baylor Children's Clinical Centre of Excellence, Princess Marina Hospital, Gaborone, Botswana.
AIDS Care. 2013;25(1):11-9. doi: 10.1080/09540121.2012.674096. Epub 2012 Apr 26.
Clinical mentoring by providers skilled in HIV management has been identified as a cornerstone of scaling-up antiretroviral treatment in Africa, particularly in settings where expertise is limited. However, little data exist on its effectiveness and impact on improving the quality-of-care and clinical outcomes, especially for HIV-infected children. Since 2008, the Botswana-Baylor Children's Clinical Centre of Excellence (COE) has operated an outreach mentoring programme at clinical sites around Botswana. This study is a retrospective review of 374 paediatric charts at four outreach mentoring sites (Mochudi, Phutadikobo, Molepolole and Thamaga) evaluating the effectiveness of the programme as reflected in a number of clinically-relevant areas. Charts from one visit prior to initiation of mentoring and from one visit after approximately one year of mentoring were assessed for statistically-significant differences (p<0.05) in the documentation of clinically-relevant indicators. Mochudi showed notable improvements in all indicators analysed, with particular improvements in documentation of pill count, viral load (VL) results, correct laboratory monitoring and correct antiretroviral therapy (ART) dosing (p<0.0001, p<0.0001, p<0.0001 and p<0.0001, respectively). Broad and substantial improvements were also seen in Molepolole, with the most improvement in disclosure documentation of all four sites. At Thamaga, improvements were restricted to CD4 documentation (p<0.001), recent VL and documented pill count (p<0.05 and p<0.05, respectively). Phuthadikobo showed the least amount of improvement across indicators, with only VL documentation and correct ART dosing showing statistically-significant improvements (p<0.05 and p<0.0001, respectively). These findings suggest that clinical mentoring may assist improvements in a number of important areas, including ART dosing and monitoring; adherence assessment and assurance; and disclosure. Clinical mentoring may be a valuable tool in scale-up of quality paediatric HIV care-and-treatment outside specialised centres. Further study will help refine approaches to clinical mentoring, including assuring mentoring translates into improved clinical outcomes for HIV-infected children.
由精通艾滋病管理的医护人员进行临床指导,已被视为扩大非洲抗逆转录病毒治疗规模的基石,尤其是在专业知识有限的地区。然而,关于其有效性以及对改善医疗质量和临床结果的影响的数据却很少,特别是对于感染艾滋病病毒的儿童而言。自2008年以来,博茨瓦纳 - 贝勒儿童卓越临床中心(COE)在博茨瓦纳各地的临床站点开展了一项外展指导计划。本研究对四个外展指导站点(莫丘迪、富塔迪科博、莫莱波洛莱和塔马加)的374份儿科病历进行了回顾性分析,评估该计划在一些临床相关领域所体现出的有效性。对指导开始前一次就诊的病历以及指导大约一年后的一次就诊病历进行评估,以分析临床相关指标记录中具有统计学意义的差异(p<0.05)。莫丘迪在所有分析指标上均有显著改善,在药丸计数记录、病毒载量(VL)结果、正确的实验室监测以及正确的抗逆转录病毒疗法(ART)剂量记录方面尤其明显(分别为p<0.0001、p<0.0001、p<0.0001和p<0.0001)。莫莱波洛莱也有广泛而显著的改善,在所有四个站点中,其在信息披露记录方面改善最为明显。在塔马加,改善仅限于CD4记录(p<0.001)、近期VL以及记录的药丸计数(分别为p<0.05和p<0.05)。富塔迪科博在各项指标上改善最少,只有VL记录和正确的ART剂量显示出统计学意义上的改善(分别为p<0.05和p<0.0001)。这些发现表明,临床指导可能有助于在多个重要领域取得改善,包括ART剂量和监测、依从性评估与保障以及信息披露。临床指导可能是在专科中心以外扩大优质儿科艾滋病护理和治疗规模的一项宝贵工具。进一步的研究将有助于完善临床指导方法,包括确保指导能够转化为感染艾滋病病毒儿童更好的临床结果。